Dr. Ilangho R P

 Dr. Ilangho RP is a renowned pulmonologist in Chennai with over three decades of experience. He specialises in the treatment of asthma, bronchitis, COPD, sleep diseases, and smoking problems. He is also an expert in bronchoscopy and other interventional pulmonology procedures.

Dr. Ilangho has held many significant positions like the Vice-President of BreatheEazy Clinic, for the Apollo Hospitals Group, India`s First Disease Management Programme and the Vice-President of the Association of Pulmonologists of Tamilnadu. He has given various talks over the radio and TV.

Besides hosting regular quizzes for medical students, Dr. Ilangho has also reviewed various international and national journals. He has a special interest in conducting research in Medicine and Life-On on an ongoing basis.

• - State University First Rank in Diploma in Tuberculosis & Respiratory Diseases (1990)
• - Served as the Vice President (Medical) – Breatheeazy Clinic, for Apollo Hospitals Group, India's First Disease Management Programme, since June 2008 till 2014. Breatheeazy Clinic Is for Asthma & COPD

• - President, Indian Medical Association, Apollo Hospitals - Thousand Lights Branch, Chennai
• - Indian Association of Bronchology - Life Member
• - Indian Medical Association - Life Member
• - Indian Chest Society – Life Member
• - ACCP (American College of Chest Physicians), USA – Indian Chapter - Life Member
• - Indian Critical Care Society – Life Member
• - Fellow of Royal College of Physicians & Surgeons of Glasgow, United Kingdom
• - Vice-President of First Association of Pulmonologists of Tamil Nadu - 2016 [Apt]
• - Member, Editorial Board, of the First Journal of Association of Pulmonologists of Tamil Nadu [Japi] 2016
• - Founder Member of Organizing Committee: FIRST TAPPCON Conference - Tamil Nadu and Pondicherry Pulmonology Conference-2015 & 2016
• - Former Member - The Global Advisory Board of: The Disease Management Association of India (DMAI)
• - Former Member - Institutional Ethical Committee -The Tamil Nadu Dr. M.G.R Medical University, Chennai, India

• - Fellow of Royal College of Physicians & Surgeons of Glasgow, United Kingdom
• - Trained in ICH-GCP (International Conference on Harmonisation Regulations - Good Clinical Practices

• Research and Publications: Many in National & International Journals & Peer Reviewer for them.
• 1) RajBSingh, Babu Abraham, Guhan AR, Ilangho RP, Sanjay Sobti. Transbronchial Lung Biopsy through the Fibreoptic Bronchoscope. A Retrospective Analysis biopsied of 256 patients. Lung India 1998; 1:10-13.
• 2) Narasimhan R, Ilangho RP, Seethalakshmi S. Polymerase Chain Reaction for Mycobacterium Tuberculosis. Lung India 1998; 1:150 – 154.
• 3) Narasimhan R, Ilangho RP. Paper presentation – in National Conference in Respiratory Medicine titled `Transbronchial Lung Biopsy – A Retrospective Analysis`, Chennai, India, 1998.
• 4) Narasimhan R, Ilangho RP, Mahadevan S. Case report – Pneumocystis Carinii Pneumonia, Lung India 1999; 1: 35-37.
• 5) Narasimhan R, Gayathri AR, Ilangho RP. Transbronchial Lung Biopsy - A Retrospective Analysis. Pulmon 2004; 6:2:44-49.
• 6) Ilangho RP, Jayaraman S. Case presentation – in National Conference in Respiratory Medicine titled `Rare Splenic Metastasis in Lung Cancer`- Ahmedabad, India, 2004.
• 7) Ilangho RP, Jayaraman S. Case presentation – in National Conference in Respiratory Medicine titled `Severe Community Acquired Pneumonia-Critical and Pulmonary Care ` - Ahmedabad, India, 2004.
• 8) Ilangho RP, Jayaraman S. Case Presentation -`Adenoid Cystic Carcinoma` in National Indian Bronchology Conference, New Delhi, India, 2005.
• 9) Ilangho RP. REVIEW SERIES: Lung disease around the world: Lung health in India, Chronic Respiratory Disease; May 2007 4:107-110.
• 10) Sharma M, Ilangho R.P.:“Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population.”European Respiratory Society, International Congress, 2015.
• 11) ERS- European Respiratory Society --2017 A] Evaluation of Asthma Control using ACQ & comparison with GINA criteria Amarendra P ,Ilangho RP B} Risk factors in OSA Meghna, Ilangho RP
• 12) R Narasimhan,B Rajagopalan,C Chandrasekhar,R Velraj, Ilangho Rp et al :Comprehensive Overview and Evidence Based Clinical Approach to Covid- 19 - An Official Consensus Statement Endorsed By Association of Pulmonologist of Tamilnadu, Journal of Association of Pulmonologist of Tamil Nadu ; 20203(4):1.DOI: 10.4103/WKMP-0215.309207
• 13) VaseemaThabassum Shaik, Ilangho Rp, K Bhaskaran :Utility of Ariscat (Assess respiratory risk in surgical patients in catalonia) score in predicting postoperative pulmonary complications in patients undergoing elective/emergency surgery in a tertiary care Hospital in India. Journal of Association of Pulmonologist of Tamil Nadu, 2021; 4(3):94. DOI: 10.4103/japt.japt_38_21
• CLINICAL RESEARCH:
• 1) Principle Investigator, of Phase IV, Open-label, non-comparative, multicentric, trial, titled ‘Use of Meropenem in the treatment of Moderate and Severe Infections’ in 2003.
• 2) Investigator (Unblinded Physician) in, global, multicenter, double-blind, comparative, randomized, Phase III trial, to evaluate `The efficacy and safety of Micafungin versus Liposomal Amphotericin B in the treatment of Invasive Candidiasis and Candidaemia`, between 2003 to 2004.
• 3) Investigator (Unblinded Physician) in Phase III, global, randomized double-blind comparative study of`` Micafungin versus Caspofungin as an antifungal treatment in patients with Invasive Candidiasis and Candidaemia`, in 2005. Abovementioned trials subjected to US FDA audit
• 4) Centre Principal Investigator, in the Writing Group of the Global Asthma Network Study Group- 2013 to date Drug Trials at various @ Apollo Hospitals, Chennai, India.

• - Asthma and Bronchitis Treatment
• - Smoking Problems
• - Tuberculosis Treatment
• - Treatment of Sleep Disorders
• - Critical Care
• - Interstitial Diseases Treatment
• - Treatment of Occupational Diseases
• - Treatment of Pleural Diseases
• - Pneumonia Treatment
• - Treatment of Lung Cancer
• - Lung Transplantation
• - Treatment of Respiratory Infections
• - Lung Failure Treatment